Rituximab Fails to Reduce Histologic Transformation (HT) Rate of Follicular Lymphoma (FL) to Diffuse Large B-Cell Lymphoma (DLBCL)

被引：2
|
作者：
Marciscano, Ariel E. [1 ]
Gupta, Neel [2 ]
Zhang, Zhigang [2 ]
Teruya-Feldstein, Julie [2 ]
Noy, Ariela [2 ]
机构：
[1] NYU, Sch Med, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
10.1182/blood.V112.11.837.837
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：310 / 310
页数：1
相关论文
共 50 条
  • [41] Phase I study of radiotherapy (RT) & durvalumab in relapsed/refractory diffuse large B-cell lymphoma (DLBCL) & follicular lymphoma (FL): The RADD study.
    Hawkes, Eliza Anne
    Manos, Kate
    Chong, Geoffrey
    Palmer, Jodie
    MacManus, Michael Patrick
    Keane, Colm
    Scott, Andrew Mark
    Shortt, Jake
    Ritchie, David
    Churilov, Leonid
    Johnston, Laura
    Witkowski, Tom
    Barraclough, Allison Anne
    Lee, Sze Ting
    Lin, Wendi
    Koldej, Rachel
    Khor, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [42] Transformation of Follicular Lymphoma into Primary Mediastinal B-Cell Lymphoma-like Large B-Cell Lymphoma
    Loveday, Tristan
    Duns, Gerben
    Rimsza, Lisa M.
    Rech, Karen
    Cook, James R.
    Robetorye, Ryan S.
    Rosenthal, Allison C.
    Ramsower, Colleen
    Yip, Tameson
    McKinney, Catherine
    Swerdlow, Steven H.
    Bhavsar, Shweta
    Steidl, Christian
    Gibson, Sarah E.
    BLOOD, 2021, 138
  • [43] Prognostic markers and angiogenesis in diffuse large B-cell lymphoma and follicular lymphoma
    Mezei, T.
    Gurzu, S.
    Raica, M.
    Cimpean, A.
    Szentirmay, J.
    Jung, J.
    VIRCHOWS ARCHIV, 2009, 455 : 17 - 18
  • [44] A Patient With Regressed Diffuse Large B-Cell Lymphoma and Aggressive Follicular Lymphoma
    Sethi, Ashish K.
    Haq, Bushra
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)
  • [45] Primary prostatic lymphoma with components of both diffuse large B-cell lymphoma (DLBCL) and MALT lymphoma
    Petrakis, G.
    Koletsa, T.
    Karavasilis, V
    Rallis, G.
    Bobos, M.
    Karkavelas, G.
    Kostopoulos, I
    HIPPOKRATIA, 2012, 16 (01) : 86 - 89
  • [46] Prognostication of diffuse large B-cell lymphoma in the rituximab era
    Ninan, Mary J.
    Wadhwa, Punit D.
    Gupta, Pankaj
    LEUKEMIA & LYMPHOMA, 2011, 52 (03) : 360 - 373
  • [47] PHARMACOKINETICS OF RITUXIMAB IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Rozman, S.
    Grabnar, I.
    Novakovic, S.
    Mrhar, A.
    Novakovic, B. Jezersek
    HAEMATOLOGICA, 2017, 102 : 688 - 688
  • [48] Rituximab maintenance therapy in diffuse large B-cell lymphoma
    Trajkova, S.
    Panovska-Stavridis, I.
    Stojanovik, A.
    Dukovski, D.
    Cevreska, L.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 : S22 - S23
  • [49] The Burden Of Illness and Prevalence In Diffuse Large B-Cell (DLBCL) and Follicular (FL) Lymphomas
    Dulac, Edward J., III
    Joy, Karen A.
    Ndindjock, Roger
    Coyle, Katharine B.
    Wade, Rolin L.
    BLOOD, 2013, 122 (21)
  • [50] Outcomes of Patients with Transformed Diffuse Large B-Cell Lymphoma (DLBCL)
    Nakashima, J.
    Cruz-Chamarro, R.
    Laborde, J.
    Kim, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E479 - E479
12345